AbstractWe have reported that histone deacetylase (HDAC) inhibitors activate a member of the INK4 family, the p19INK4d gene, causing G1 phase arrest. We report here that HDAC inhibitor, Trichostatin A, activates another member of the INK4 family, the p18INK4c gene, through its promoter in Jurkat cells. Interestingly, the activation patterns of the p18INK4c gene were different from those of p19INK4d. Furthermore, mouse embryo fibroblasts lacking p18Ink4c or p18Ink4c/p19Ink4d were resistant to the growth inhibitory effects of TSA as compared to their wild-type counterpart. Our findings suggest that p18INK4c is involved in TSA-mediated cell growth inhibition and cooperates with p19INK4d
The histone deacetylase inhibitor trichostatin A (TsA) potently induces 5-lipoxygenase (5-LO) promot...
Remodeling of the chromatin template by inhibition of histone deacetylase (HDAC) activities represen...
AbstractHistone deacetylase (HDAC) inhibitors are being developed as new clinical agents in cancer t...
AbstractWe have reported that histone deacetylase (HDAC) inhibitors activate a member of the INK4 fa...
AbstractHistone deacetylase (HDAC) inhibitors arrest human tumor cells at the G1 phase of the cell c...
AbstractHistone deacetylase (HDAC) inhibitors arrest human tumor cells at the G1 phase of the cell c...
AbstractThe histone deacetylase inhibitor trichostatin A (TSA) has been previously shown to block ce...
peer reviewedThe histone deacetylase inhibitor trichostatin A (TsA) potently induces 5-lipoxygenase ...
Inhibitors of histone deacetylases (HDACi) have shown promising effects in preclinical applications ...
peer reviewedHistone deacetylase inhibitors induce cell cycle arrest and apoptosis in tumor cells an...
AbstractThe cell cycle inhibitor p16INK4a is inactivated in many human tumors and in families with h...
Histone deacetylase inhibitors induce cell cycle arrest and apoptosis in tumor cells and are therefo...
AbstractTreatment of cultured cells with sodium butyrate, that is the histone deacetylase inhibitor,...
The INK4 family of cyclin-dependent kinase (CDK) inhibitors negatively regulates cyclin D-dependent ...
The INK4 family of cyclin-dependent kinase (CDK) inhibitors negatively regulates cyclin D-dependent ...
The histone deacetylase inhibitor trichostatin A (TsA) potently induces 5-lipoxygenase (5-LO) promot...
Remodeling of the chromatin template by inhibition of histone deacetylase (HDAC) activities represen...
AbstractHistone deacetylase (HDAC) inhibitors are being developed as new clinical agents in cancer t...
AbstractWe have reported that histone deacetylase (HDAC) inhibitors activate a member of the INK4 fa...
AbstractHistone deacetylase (HDAC) inhibitors arrest human tumor cells at the G1 phase of the cell c...
AbstractHistone deacetylase (HDAC) inhibitors arrest human tumor cells at the G1 phase of the cell c...
AbstractThe histone deacetylase inhibitor trichostatin A (TSA) has been previously shown to block ce...
peer reviewedThe histone deacetylase inhibitor trichostatin A (TsA) potently induces 5-lipoxygenase ...
Inhibitors of histone deacetylases (HDACi) have shown promising effects in preclinical applications ...
peer reviewedHistone deacetylase inhibitors induce cell cycle arrest and apoptosis in tumor cells an...
AbstractThe cell cycle inhibitor p16INK4a is inactivated in many human tumors and in families with h...
Histone deacetylase inhibitors induce cell cycle arrest and apoptosis in tumor cells and are therefo...
AbstractTreatment of cultured cells with sodium butyrate, that is the histone deacetylase inhibitor,...
The INK4 family of cyclin-dependent kinase (CDK) inhibitors negatively regulates cyclin D-dependent ...
The INK4 family of cyclin-dependent kinase (CDK) inhibitors negatively regulates cyclin D-dependent ...
The histone deacetylase inhibitor trichostatin A (TsA) potently induces 5-lipoxygenase (5-LO) promot...
Remodeling of the chromatin template by inhibition of histone deacetylase (HDAC) activities represen...
AbstractHistone deacetylase (HDAC) inhibitors are being developed as new clinical agents in cancer t...